SCHEMBL12435119

SCHEMBL12435119

CC(=O)N[C@H](C(C)C)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.37
KDM4E B2RXH2 2/20 0.33
NFKB1 P19838 2/20 0.33
POLB P06746 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
ALOX15 P16050 1/20 0.33
PTGS2 P35354 1/20 0.33
THPO P40225 1/20 0.33
RECQL P46063 1/20 0.33
BLM P54132 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ADAM17 P78536 1/20 0.33
DPP4 P27487 1/20 0.32
CA2 P00918 2/20 0.32
PTGS1 P23219 1/20 0.32
MMP12 P39900 1/20 0.32
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11911982 1.00 ALDH1A1 (0.37) ALDH1A1KDM4ENFKB1POLBMAPT
SCHEMBL12344320 1.00 ALDH1A1 (0.37) ALDH1A1KDM4ENFKB1POLBMAPT
SCHEMBL14266502 0.89 NFKB1 (0.36) ALDH1A1KDM4ENFKB1POLBMAPT
SCHEMBL25015671 0.85 ALDH1A1 (0.34) ALDH1A1KDM4ENFKB1POLBMAPT
SCHEMBL801285 0.83 ALDH1A1 (0.33) ALDH1A1KDM4ENFKB1POLBMAPT
SCHEMBL801237 0.80 ALDH1A1 (0.34) ALDH1A1KDM4ENFKB1MAPTTHRB
SCHEMBL801063 0.80 ALDH1A1 (0.34) ALDH1A1KDM4ENFKB1MAPTTHRB
SCHEMBL18612347 0.80 ALDH1A1 (0.35) ALDH1A1KDM4ENFKB1MAPTTHRB
SCHEMBL7940721 0.77 DPP4 (0.35) ALDH1A1POLBMAPTSMN1; SMN2DPP4
SCHEMBL12207195 0.77 DPP4 (0.35) ALDH1A1NFKB1POLBTHPOBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11834408-B2 Compounds for the treatment of SARS PURDUE RESEARCH FOUNDATION (US) 2023-12-05 US disclosed
US-20110178092-A1 HIV-1 Protease Inhibitors UNIVERSITY OF MARYLAND, COLLEGE PARK 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178092-A1 HIV-1 Protease Inhibitors SERPINB1, PRSS1, TMPRSS4 ALDH1A1 2716/4885KDM4E 1140/4885NFKB1 2210/4885
US-11834408-B2 Compounds for the treatment of SARS ACE2, SARS1, ACE ALDH1A1 2923/4885KDM4E 4049/4885NFKB1 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.